Formulation & Device Lifecycle Management for Biotherapeutics - The Value of Platform Technologies

27 September 2022 15:30 - 16:00

This presentation will discuss advantages and disadvantages inherent to using formulation and device platform technologies to improve the drug delivery profile of medicinal products, highlight development and commercialization aspects that can be leveraged across different molecules and indications, as well as aspects that need to be assessed for each molecule individually.

Andrew Ratz, Vice President, Drug Delivery and Device Development, Eli Lilly